» Articles » PMID: 31526517

Trends of Cardiac Complications in Patients With Rheumatoid Arthritis: Analysis of the United States National Inpatient Sample; 2005-2014

Overview
Publisher Elsevier
Date 2019 Sep 19
PMID 31526517
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rheumatoid arthritis (RA) is a chronic inflammatory condition. Chronic inflammation is associated with atherosclerosis, hypertension, diabetes, chronic obstructive pulmonary disease (COPD), chronic kidney disease. But sparse data are available regarding the trends of cardiovascular diseases and complications in RA. We conducted a National Inpatient Sample database analysis to demonstrate the trends of cardiac complications in patients with RA.

Methods: We used National Inpatient Sample data from 2005 to 2014 to identify admissions with the diagnosis of RA and identified who had associated cardiovascular complications also. The International Classification of Diseases-9th Revision-Clinical Modification codes were used for the diagnoses of RA; congestive heart failure (CHF), acute myocardial infarction (AMI), and atrial fibrillation (AF).

Results: A statistically significant increasing trend of AMI, CHF, and AF was found. Independent predictors of mortality in RA patients with AMI were age (OR 1.03, CI 1.02-1.04; P < 0.001), COPD (OR 1.67, CI 1.40-2.00; P < 0.001), cerebrovascular disease (OR 2.207, CI 1.71-2.86; P < 0.001), renal disease (OR 1.42, CI 1.16-1.75; P = 0.001), and alcohol abuse (OR 2.73, CI 1.73-4.32; P < 0.001). Independent predictors of mortality in RA patients with CHF were age (odds ratio [OR] 1.02, confidence interval [CI] 1.017-1.024; P < 0.001]), COPD (OR 1.09, CI 1.01-1.18; P = 0.023), cerebrovascular disease (OR 1.67, CI 1.44-1.95; P < 0.001), renal disease (OR 1.16, CI 1.07-1.27; P = 0.001). Independent predictors of mortality in RA patients with AF were age (OR 1.02, CI 1.02-1.03; P < 0.001), race (OR 1.16, CI 1.02-1.31; P = 0.022), COPD (OR 1.56, CI 1.42-1.71; P < 0.001), peripheral arterial disease (OR 1.34, CI 1.16-1.53; P < 0.001), cerebrovascular disease (OR 2.27, CI 1.0-2.58; P < 0.001), renal disease (OR 1.60, CI 1.44-1.80; P < 0.001). The mortality trend has increased significantly in the CHF (P = 0.025) and AF (P = 0.042) groups during this study period.

Conclusions: We have found a significant increase in trend of cardiovascular complications in RA patients. The proportion of patients, with cardiovascular comorbidities, have also been increased significantly.

Citing Articles

Emergencies in inflammatory rheumatic diseases.

Auyezkhankyzy D, Izekenova A, Kocyigit B Rheumatol Int. 2024; 44(9):1637-1646.

PMID: 38981903 PMC: 11343811. DOI: 10.1007/s00296-024-05660-y.


The association between antiphospholipid syndrome and atrial fibrillation: a single center retrospective case-control study.

Zhou Z, Liu Y PeerJ. 2024; 12:e17617.

PMID: 38948200 PMC: 11214423. DOI: 10.7717/peerj.17617.


The Relationship between Seropositive Rheumatoid Arthritis and Congestive Heart Failure: A Nationwide Longitudinal Cohort Study in Korea.

Kim Y, Hong J, Kim H, Sheen S, Han I, Kim J J Pers Med. 2024; 14(6).

PMID: 38929836 PMC: 11204740. DOI: 10.3390/jpm14060615.


Evolocumab prevents atrial fibrillation in rheumatoid arthritis rats through restraint of PCSK9 induced atrial remodeling.

Han X, Gao Y, He M, Luo Y, Wei Y, Duan Y J Adv Res. 2023; 61:211-221.

PMID: 37709197 PMC: 11258665. DOI: 10.1016/j.jare.2023.09.007.


Rheumatoid arthritis increases the risk of heart failure-current evidence from genome-wide association studies.

Wang M, Mei K, Chao C, Di D, Qian Y, Wang B Front Endocrinol (Lausanne). 2023; 14:1154271.

PMID: 37288294 PMC: 10242133. DOI: 10.3389/fendo.2023.1154271.